23andMe samples
vendredi 8 février 2019 à 01:00The DNA sampling company 23andMe just sold a lot of shares to a Big Pharma company which can now use all the DNA samples that people sent in.
There are two bad things about this:
- Whatever research benefits these people's DNA makes possible is available only to one pharma company.
- That company is now in a position to violate lots of people's privacy.